International audiencePrimary HIV-1 infections (PHI) with non-B subtypes are increasing in developed countries while transmission of HIV-1 harboring antiretroviral resistance-associated mutations (RAMs) remains a concern. This study assessed non-B HIV-1 subtypes and RAMs prevalence among patients with PHI in university hospitals of Marseille, Southeastern France, in 2005-2015 (11 years). HIV-1 sequences were obtained by inhouse protocols from 115 patients with PHI, including 38 for the 2013-2015 period. On the basis of the phylogenetic analysis of the reverse transcriptase region, non-B subtypes were identified in 31% of these patients. They included 3 different subtypes (3A, 1C, 4F), 23 circulating recombinant forms (CRFs) (CRF02_AG, best ...
To evaluate the prevalence of transmitted drug resistance (TDR) and non-B subtypes in patients with ...
International audienceObjectivesPatients with primary HIV-1 infection (PHI) are a particular populat...
International audienceBackground: Our study describes the prevalence of transmitted drug resistance ...
International audiencePrimary HIV-1 infections (PHI) with non-B subtypes are increasing in developed...
Background: Prevalence of HIV-1 non-B subtypes has increased overtime in patients diagnosed at the t...
BackgroundOur study describes the prevalence of transmitted drug resistance (TDR) among 1318 French ...
International audienceObjectives: We estimated the prevalence of transmitted-drug-resistance-associa...
Background. To analyze the time trends of the viral subtype distributions according to gender, risk ...
To evaluate the prevalence of transmitted drug resistance (TDR) and non-B subtypes in patients with ...
International audienceObjectivesPatients with primary HIV-1 infection (PHI) are a particular populat...
International audienceBackground: Our study describes the prevalence of transmitted drug resistance ...
International audiencePrimary HIV-1 infections (PHI) with non-B subtypes are increasing in developed...
Background: Prevalence of HIV-1 non-B subtypes has increased overtime in patients diagnosed at the t...
BackgroundOur study describes the prevalence of transmitted drug resistance (TDR) among 1318 French ...
International audienceObjectives: We estimated the prevalence of transmitted-drug-resistance-associa...
Background. To analyze the time trends of the viral subtype distributions according to gender, risk ...
To evaluate the prevalence of transmitted drug resistance (TDR) and non-B subtypes in patients with ...
International audienceObjectivesPatients with primary HIV-1 infection (PHI) are a particular populat...
International audienceBackground: Our study describes the prevalence of transmitted drug resistance ...